Biotech · Private company · Worcester, MA, US
Xtop Biotherapeutics Inc.
Track this companyFree. Adds Xtop Biotherapeutics Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards1
- Study of CB-101: A Novel First-in-Class Trispecific Antibody Targeting ROR1, EpCAM, and CD3 for the Treatment of Colorectal Cancer and Other Solid TumorsFiscal year 2026 · $400KNIH RePORTER 1R43CA310454-01A1 · fetched Nov 12, 2026